{"doi":"10.1002/hep.31288","title":"Epidemiology of Hepatocellular Carcinoma","abstract":"<jats:p>Liver cancer is a major contributor to the worldwide cancer burden. Incidence rates of this disease have increased in many countries in recent decades. As the principal histologic type of liver cancer, hepatocellular carcinoma (HCC) accounts for the great majority of liver cancer diagnoses and deaths. Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain, at present, the most important global risk factors for HCC, but their importance will likely decline in the coming years. The effect of HBV vaccination of newborns, already seen in young adults in some countries, will be more notable as vaccinated cohorts age. In addition, effective treatments for chronic infections with both HBV and HCV should contribute to declines in the rates of viral‐associated HCC. Unfortunately, the prevalence of metabolic risk factors for HCC, including metabolic syndrome, obesity, type II diabetes and non‐alcoholic fatty liver disease (NAFLD) are increasing and may jointly become the major cause of HCC globally. Excessive alcohol consumption also remains an intractable risk factor, as does aflatoxin contamination of food crops in some parts of the world. While significant efforts in early diagnosis and better treatment are certainly needed for HCC, primary prevention efforts aimed at decreasing the prevalence of obesity and diabetes and controlling mycotoxin growth, are just as urgently required.</jats:p>","journal":"Hepatology","year":2020,"id":47237,"datarank":0.0,"base_score":7.680637427560936,"endowment":7.680637427560936,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2165,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":25,"is_dataset":false,"is_dataset_confidence":0.9623,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":217920,"name":"Jessica L. Petrick","orcid":"0000-0001-6580-450X","position":1,"is_corresponding":false},{"id":217921,"name":"Hashem B. El‐Serag","orcid":"0000-0001-5964-7579","position":2,"is_corresponding":false},{"id":217919,"name":"Katherine A. McGlynn","orcid":"0000-0003-2329-9933","position":0,"is_corresponding":true}],"reference_count":87,"raw_metadata":null,"created_at":"2026-07-18T14:18:31.320809Z","pmid":"32319693","pmcid":"PMC7577946","fwci":160.7494,"citation_percentile":0.9999096,"influential_citations":48,"oa_status":"green","license":"http://doi.wiley.com/10.1002/tdm_license_1.1","views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[{"doi":"10.6084/m9.figshare.19654527.v1","title":"Additional file 2 of KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma","publisher":"figshare","resource_type":"Presentation"},{"doi":"10.6084/m9.figshare.19654527","title":"Additional file 2 of KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma","publisher":"figshare","resource_type":"Presentation"},{"doi":"10.6084/m9.figshare.17140705.v1","title":"Additional file 1 of Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.17140705","title":"Additional file 1 of Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.17140714.v1","title":"Additional file 2 of Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.17140714","title":"Additional file 2 of Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.17140717.v1","title":"Additional file 3 of Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.17140717","title":"Additional file 3 of Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19625502.v1","title":"Additional file 1 of Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19625502","title":"Additional file 1 of Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19654524.v1","title":"Additional file 1 of KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19654524","title":"Additional file 1 of KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20003207.v1","title":"Additional file 1 of A clinical trial of super-stable homogeneous lipiodol-nanoICG formulation-guided precise fluorescent laparoscopic hepatocellular carcinoma resection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20003207","title":"Additional file 1 of A clinical trial of super-stable homogeneous lipiodol-nanoICG formulation-guided precise fluorescent laparoscopic hepatocellular carcinoma resection","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20153143.v1","title":"Additional file 2 of Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20153143","title":"Additional file 2 of Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21321418.v1","title":"Additional file 1 of RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21321418","title":"Additional file 1 of RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21622437.v1","title":"Additional file 1 of Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21622437","title":"Additional file 1 of Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21622440.v1","title":"Additional file 2 of Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21622440","title":"Additional file 2 of Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22609766.v1","title":"Additional file 1 of Characterization of a lipid droplet and endoplasmic reticulum stress related gene risk signature to evaluate the clinical and biological value in hepatocellular carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22609766","title":"Additional file 1 of Characterization of a lipid droplet and endoplasmic reticulum stress related gene risk signature to evaluate the clinical and biological value in hepatocellular carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22622068.v1","title":"Additional file 1 of Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants","publisher":"figshare","resource_type":"JournalArticle"}],"topics":[{"topic_type":"field_of_study","value":"Liver Disease Diagnosis and Treatment","extra":null},{"topic_type":"field_of_study","value":"Hepatocellular Carcinoma Treatment and Prognosis","extra":null},{"topic_type":"field_of_study","value":"Hepatitis B Virus Studies","extra":null},{"topic_type":"field_of_study","value":"Medicine","extra":null},{"topic_type":"mesh_term","value":"Alcohol Drinking","extra":null},{"topic_type":"mesh_term","value":"Female","extra":null},{"topic_type":"mesh_term","value":"Hepatitis B","extra":null},{"topic_type":"mesh_term","value":"Hepatitis C","extra":null},{"topic_type":"mesh_term","value":"Carcinoma, Hepatocellular","extra":null},{"topic_type":"mesh_term","value":"Humans","extra":null},{"topic_type":"mesh_term","value":"Liver Neoplasms","extra":null},{"topic_type":"mesh_term","value":"Male","extra":null},{"topic_type":"mesh_term","value":"Incidence","extra":null},{"topic_type":"mesh_term","value":"Genetic Predisposition to Disease","extra":null},{"topic_type":"mesh_term","value":"Metabolic Syndrome","extra":null},{"topic_type":"mesh_term","value":"Non-alcoholic Fatty Liver Disease","extra":null},{"topic_type":"keyword","value":"Hepatocellular carcinoma","extra":null},{"topic_type":"keyword","value":"Epidemiology","extra":null},{"topic_type":"keyword","value":"Medicine","extra":null},{"topic_type":"keyword","value":"Carcinoma","extra":null},{"topic_type":"keyword","value":"Internal medicine","extra":null},{"topic_type":"keyword","value":"Oncology","extra":null},{"topic_type":"keyword","value":"General surgery","extra":null},{"topic_type":"sdg","value":"Good health and well-being","extra":"0"}]}